Life Sciences Times

Intrance Medical Systems Establishes U.S. Operations and Names Patrick Shea Chief Executive Officer

The “Rare Disease Company Coalition” Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development

FSD Pharma Announces Filing of Criminal Complaint Against Former Chief Financial Officer

Lunaphore Announces Appointment of Matthias Weber, Former President of Leica Biosystems, to Board of Directors

Clarify Health Launches Real-World Evidence on Health Disparities

ILC Therapeutics Announces Board Changes and Funding Round to Accelerate Covid-19 Drug

Flare Therapeutics Launches with $82 Million Series A Financing

Nuclera Acquires E Ink Digital Microfluidics Unit

$50 Million Follow-on Equity Investment from Sixth Street Growth Caps $135 Million

Labcorp and the U.S. Department of Health and Human Services Join Forces to Raise Awareness of COVID-19 Treatments